Specialties
- Endocrine Surgery
- Head and Neck Surgery
Education
- MD, University of Washington School of Medicine, Seattle, WA
- MS, Masters of Science - Health Services Research & Health Policy University of Washington School of Public Health, Seattle, WA
- General Surgery Internship, University of Vermont, Burlington, VT
- Otolaryngology-Head & Neck Surgery Residency, University of Vermont, Burlington, VT and Dartmouth Hitchcock Medical Center, Lebanon, NH
- Senior fellowship Clinical Research, Robert Wood Johnson Clinical Scholars Program, University of Washington, Seattle, WA
- Research Grant & Fellowship, Fulbright U.S. Global Research Scholar U.S. Department of State
Clinical Specialties
Dr. Davies is certified by the American Board of Otolaryngology. She specializes in surgical treatment of disorders of the thyroid and parathyroid glands, head and neck cancer, voice and swallowing disorders, and skin cancer. She has a dual appointments in the Department of Surgery – Division of Endocrine Surgery and the Department of Otolaryngology – Division of Head & Neck Surgical Oncology.
Dr. Davies provides a wide range of services including Thyroid Surgery, Thyroidectomy, Thyroid Lobectomy, Total Thyroidectomy, Resection Of Substernal Goiter, Parathyroid Surgery, Minimally Invasive Parathyroidectomy, Central Neck Dissection, Functional Neck Dissection, Modified Radical Neck Dissection, Fine Needle Aspiration (FNA), Neck Ultrasound, Parotidectomy, Vocal Cord Injection, Tracheostomy, Esophageal Dilation, Skin Cancer Reconstruction.
Research Interests
Dr. Davies is internationally recognized for her research on the epidemiology of thyroid cancer and its impact on population health. Her current projects focus on de-escalation of thyroid cancer treatment for appropriately selected patients to optimize outcomes while minimizing side effects and risks of treatment; and developing research evidence to optimize the patient experience and support joint decision making between physicians and their patients in healthcare for thyroid and head and neck cancer.
Recent Publications
Impact of COVID-19 restrictions on thyroid cancer diagnoses in a comprehensive cancer center (2017-2023).
Mann H, Dimon E, Zhang Y, Arroyo N, Adil A, Zhang Y, Alagoz O, Fernandes-Taylor S, Aiello Bowles EJ, Davies L, Francis DO
PLoS One 2026; 21(1): e0340347
[PubMed ID: 41538388]Do discharge delays explain longer stays at veterans health administration hospitals?
Lucas BP, Weinberger DM, Vashi AA, Smith J, Korves C, Justice AC, Neugaard BI, Davies L
BMC Health Serv Res 2025 Dec 12; 25(1): 1595
[PubMed ID: 41387858]The Year in Thyroidology 2025-Basic Science, Clinical Science, Surgical Science.
Davies L, Franco AT, Haugen B
Thyroid 2025 Dec; 35(12): 1353-1358
[PubMed ID: 41346013]Trends in Colon Cancer Colectomy Volume and Inpatient Costs, 2018-2023: A Medicare Analysis.
Newton LE, Korves C, Zwain G, Fowler XP, Bellamkonda K, Rosa S, Denny J, Huynh J, Weinberger DM, Justice A, Vashi A, Goodney PP, Wilson MZ, Davies L
J Surg Res 2025 Dec; 316: 229-239
[PubMed ID: 41337807]Emergency Department Utilization by Veterans for Low-Acuity Conditions After Virtual Care Expansion.
Ramachandran A, Tran LD, Asch S, Boothroyd D, Justice A, Davies L, Vashi A
JAMA Netw Open 2025 Nov 03; 8(11): e2545696
[PubMed ID: 41296481]